Erratum Heart Rhythm Volume 8, Issue 4, (April 2011)

Slides:

Advertisements

Similar presentations

Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.

Advertisements

Benefit of magnetic resonance–conditional cardiac resynchronization therapy defibrillator: A case of cardiac sarcoidosis–involved cervical extradural lesion.

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Management of mitral regurgitation. See legend for Fig

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;

Volume 12, Issue 10, Pages (October 2015)

Assessment of Intraventricular Mechanical Dyssynchrony and Prediction of Response to Cardiac Resynchronization Therapy: Comparison between Tissue Doppler.

Volume 5, Issue 8, Pages (August 2008)

Volume 14, Issue 4, Pages (April 2017)

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation Ratika Parkash, MD, MSc, François Philippon,

Volume 13, Issue 12, Pages (December 2016)

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection Derek V. Exner, MD, MPH, David.

Volume 5, Issue 4, Pages (April 2008)

Volume 10, Issue 10, Pages (October 2013)

Volume 12, Issue 3, Pages (March 2015)

Volume 6, Issue 11, Pages (November 2009)

Volume 10, Issue 10, Pages (October 2013)

Volume 13, Issue 1, Pages (January 2016)

Serial multidetector computed tomography assessment of left ventricular reverse remodeling, mass, and regional wall stress after restrictive mitral annuloplasty.

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Volume 6, Issue 4, Pages (April 2009)

Volume 9, Issue 8, Pages S3-S13 (August 2012)

Volume 11, Issue 1, Pages (January 2014)

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Thinking beyond resynchronization therapy in the failing heart

Sexual Activity and Chronic Heart Failure

Volume 9, Issue 4, Pages (April 2012)

Volume 7, Issue 1, Pages (January 2010)

Volume 15, Issue 9, Pages (September 2018)

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

Juan A. Crestanello, MD, Richard C. Daly, MD

Volume 12, Issue 4, Pages (April 2015)

Volume 9, Issue 1, Pages (January 2012)

Mahesh Anantha Narayanan et al. JACEP 2017;3:

Volume 5, Issue 8, Pages (August 2008)

Ethnic and racial disparities in cardiac resynchronization therapy

Volume 15, Issue 1, Pages (January 2018)

Volume 13, Issue 8, Pages (August 2016)

Volume 14, Issue 12, Pages (December 2017)

Volume 4, Issue 2, (February 2007)

Volume 15, Issue 1, Pages (January 2018)

Volume 15, Issue 2, Pages (February 2018)

Volume 14, Issue 4, Pages (April 2017)

Left Ventricular Reconstructive Surgery in Ischemic Dilated Cardiomyopathy Complicated With Cardiogenic Shock Koji Takeda, MD, Goro Matsumiya, MD, Hajime.

Volume 7, Issue 11, (November 2010)

Impact of physiologic pacing versus right ventricular pacing among patients with left ventricular ejection fraction greater than 35%: A systematic review.

Volume 7, Issue 7, Pages (July 2010)

Volume 12, Issue 10, Pages (October 2015)

Volume 9, Issue 8, Pages S14-S17 (August 2012)

Erratum The American Journal of Human Genetics

Michael R. Gold, MD, PhD, FHRS Heart Rhythm

Volume 15, Issue 1, Pages (January 2018)

Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep

Intangible benefits of volunteering with the Heart Rhythm Society

Volume 10, Issue 4, Pages (April 2013)

HRS collaborates with leading medical societies to launch a voluntary laboratory accreditation program and drive quality improvement John D. Day, MD,

Volume 12, Issue 12, Pages (December 2015)

Miki Yokokawa, MD, Fred Morady, MD, FACC, Frank Bogun, MD, FACC

Time course of changes in left ventricular ejection fraction (LVEF) and left ventricular diastolic dimension (LVDd) in 13 patients with the development.

Cumulative survival without events during 1 year in patients with preserved systolic function (left ventricular ejection fraction (LVEF) >40%) and with.

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

Flow chart patient inclusion.

Average left ventricular ejection fraction (LVEF) values during the 1 year of observation in patients with preserved systolic function (LVEF >40%) and.

Rick A. Nishimura et al. JACC 2017;70:

Volume 14, Issue 1, (January 2017)

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

Change in 6 min walk distance at 12 months in subgroups defined by baseline characteristics. The mean (95% CI) for the difference between CABG and medical.

David H. Harpole, MD, Stanley A. Gall, MD, Walter G. Wolfe, MD, J

Volume 16, Issue 6, Pages (June 2019)

Presentation transcript:

Erratum Heart Rhythm Volume 8, Issue 4, (April 2011) Heart Rhythm Volume 8, Issue 4, (April 2011) DOI: 10.1016/j.hrthm.2011.03.004 Copyright © 2011 Heart Rhythm Society Terms and Conditions

Figure 1 New York Heart Association (NYHA) class and left ventricular systolic function improved with cardiac resynchronization therapy (CRT) in both groups. Assessment of the delta/degree of change revealed more benefit in patients with dilated cardiomyopathy (DCM). ICM = ischemic cardiomyopathy; LVEF = left ventricular ejection fraction. Heart Rhythm 2011 8, DOI: (10.1016/j.hrthm.2011.03.004) Copyright © 2011 Heart Rhythm Society Terms and Conditions